Positive results from midstage trial of Pfizer’s cancer cachexia drug

Pfizer announced positive results from a midstage trial of its experimental drug for cancer cachexia, a condition that causes cancer patients to lose weight and appetite. The drug, ponsegromab, showed

Detail

Major Cost Savings and Product Launches Ahead: $1 Billion in Cuts, 10 New Products on the Horizon

Moderna announced plans to slash $1.1 billion in expenses by 2027 and introduce new products following a decline in its Covid business. The biotech company aims for 10 new product

Detail